Alanil-glutamina - 20% *100 ML

This tender, originating from Romania and published via the TED (Tenders Electronic Daily) platform, seeks the procurement of a specific pharmaceutical product: ALANIL-GLUTAMINA. The item is described as a concentrate for solution for infusion, with a concentration of 20% and packaged in 100ml vials. This equates to a dosage of 200mg/ml in a 100ml volume.

The contracting authority, managed by the Publications Office of the European Union, is initiating this procurement process to acquire essential medical supplies. ALANIL-GLUTAMINA, also known as Alanine-Glutamine, is a dipeptide commonly used in clinical nutrition to provide a readily available source of amino acids, particularly for patients experiencing metabolic stress or requiring parenteral nutrition. It is often administered intravenously to support recovery and prevent muscle breakdown.

Typical requirements for such a tender would include ensuring the product meets stringent quality standards, adhering to European Pharmacopoeia or equivalent national regulations. Suppliers are expected to demonstrate their ability to provide a stable and sterile product with a defined shelf-life. Furthermore, bidders will likely need to provide documentation regarding manufacturing practices, quality control procedures, and relevant certifications. The procurement will also involve considerations for packaging, labelling in accordance with Romanian and EU regulations, and timely delivery to designated healthcare facilities within Romania. Economic operators interested in participating should review the full tender documentation for specific eligibility criteria, submission deadlines, and detailed technical specifications.